EUVIMEDEUVIMED entdecken
Crossref

Blocking the ADAM9 / ITGAV Pathway Ameliorates Sepsis‐Induced Acute Lung Injury by Promoting Macrophage Efferocytosis

Long-Zhu Li, Wan-Jie Gu, Xiang-Kun Yuan, Wai-Meng Fan, Lu-Ming Zhang, Zhong-Kai Qu, Feng-Zhi Zhao, Hai-Yan Yin iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501079r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Long-Zhu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Acute Lung Injury, ADAM Proteins, Macrophages, Sepsis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Projects in Guangzhou, Key Areas of General Colleges and Universities in Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Successfully inhibiting sepsis‐induced acute lung injury (ALI) hinges on clearing apoptotic neutrophils; however, the underlying mechanisms of this process remain elusive. In the present study, we aim to investigate how ADAM9 regulates macrophage efferocytosis during ALI. In the lipopolysaccharide (LPS)‐induced ALI mice, inhibiting ADAM9 in macrophages significantly improved ALI, simultaneously reducing the number of macrophages and neutrophils in BALF, along with a decrease in pro‐inflammatory cytokines, including IFN‐γ, iNOS, and an increase in IL‐4, IL‐10. In vitro, downregulation of ADAM9 expression in bone marrow‐derived macrophages (BMDMs) improved macrophage efferocytosis to apoptotic polymorphonuclear leukocytes (PMNs). Besides, we demonstrated that ADAM9 in BMDMs could directly bind to ITGAV in PMNs; inhibiting ITGAV expression on PMNs effectively improved ADAM9‐mediated macrophage efferocytosis. Blocking the interaction between ADAM9 and ITGAV may ameliorate sepsis‐induced ALI by promoting macrophage efferocytosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryADAM ProteinsMacrophagesSepsisMembrane ProteinsPhagocytosisAnimalsMiceMice, Inbred C57BLMaleLipopolysaccharidesApoptosisNeutrophilsSignal TransductionEfferocytosis

Stichwörter der Autor:innen

ADAM9ITGAVacute lung injuryefferocytosismacrophage

Substanzen

ADAM ProteinsMembrane ProteinsAdam9 protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, China.

ORCID-Profile: Hai-Yan Yin

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Projects in Guangzhou
  • Key Areas of General Colleges and Universities in Guangdong Province
  • 2021 Annual Medical Teaching and Education Management Reform Research Project of Jinan University
  • Fundamental Research Funds for The Central Universities
  • Medical Scientific Research Foundation of Guangdong Province, China

Zitieren

APA

Li, L. Z., Gu, W. J., Yuan, X. K., Fan, W. M., Zhang, L. M., Qu, Z. K., Zhao, F. Z., & Yin, H. Y. (2025). Blocking the ADAM9 / ITGAV Pathway Ameliorates Sepsis‐Induced Acute Lung Injury by Promoting Macrophage Efferocytosis. The FASEB Journal. https://doi.org/10.1096/fj.202501079r

Vancouver

Li LZ, Gu WJ, Yuan XK, Fan WM, Zhang LM, Qu ZK, et al. Blocking the ADAM9 / ITGAV Pathway Ameliorates Sepsis‐Induced Acute Lung Injury by Promoting Macrophage Efferocytosis. The FASEB Journal. 2025. doi:10.1096/fj.202501079r

BibTeX
@article{Li2025,
  author = {Li, Long-Zhu and Gu, Wan-Jie and Yuan, Xiang-Kun and Fan, Wai-Meng and Zhang, Lu-Ming and Qu, Zhong-Kai and Zhao, Feng-Zhi and Yin, Hai-Yan},
  title = {Blocking the ADAM9 / ITGAV Pathway Ameliorates Sepsis‐Induced Acute Lung Injury by Promoting Macrophage Efferocytosis},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501079r}
}
Kostenlos starten →